Resumen de acción LALPATHLAB
Dr. Lal PathLabs Limited se dedica a la explotación de laboratorios para la realización de investigaciones patológicas en la India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Competidores de Dr. Lal PathLabs Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,328.85 |
| 52 Week High | ₹2,767.10 |
| 52 Week Low | ₹1,888.10 |
| Beta | 0.28 |
| 1 Month Change | 9.40% |
| 3 Month Change | -2.98% |
| 1 Year Change | 20.65% |
| 3 Year Change | -18.56% |
| 5 Year Change | 123.01% |
| Change since IPO | 182.28% |
Noticias y actualizaciones recientes
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Recent updates
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?
Apr 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) A Risky Investment?
Feb 17With EPS Growth And More, Dr. Lal PathLabs (NSE:LALPATHLAB) Is Interesting
Jan 20Why You Should Care About Dr. Lal PathLabs' (NSE:LALPATHLAB) Strong Returns On Capital
Dec 06Here's Why I Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today
Oct 13Does Dr. Lal PathLabs (NSE:LALPATHLAB) Have A Healthy Balance Sheet?
Aug 26Rentabilidad de los accionistas
| LALPATHLAB | IN Healthcare | Mercado IN | |
|---|---|---|---|
| 7D | 0.06% | -0.8% | 1.8% |
| 1Y | 20.7% | 65.6% | 46.4% |
Rentabilidad vs. Industria: LALPATHLAB obtuvo unos resultados inferiores a los del sector Indian Healthcare , que el año pasado arrojó un rendimiento del 61.4%.
Rentabilidad vs. Mercado: LALPATHLAB obtuvo unos resultados inferiores a los del mercado Indian, que fue del 46.1% el año pasado.
Volatilidad de los precios
| LALPATHLAB volatility | |
|---|---|
| LALPATHLAB Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: LALPATHLAB no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de LALPATHLAB (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1949 | 4,048 | Bharath Uppiliappan | www.lalpathlabs.com |
Dr. Lal PathLabs Limited se dedica a la explotación de laboratorios para la realización de investigaciones patológicas en India y a escala internacional. La empresa ofrece investigaciones patológicas de diversas ramas de la bioquímica, hematología, histopatología, microbiología, electroforesis, inmunoquímica, inmunología, virología, citología y otras investigaciones patológicas y radiológicas. También ofrece programas de formación.
Resumen de fundamentos de Dr. Lal PathLabs Limited
| Estadísticas fundamentales de LALPATHLAB | |
|---|---|
| Capitalización bursátil | ₹193.41b |
| Beneficios(TTM) | ₹3.30b |
| Ingresos (TTM) | ₹21.72b |
58.6x
Ratio precio-beneficio (PE)8.9x
Ratio precio-ventas (PS)¿Está LALPATHLAB sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de LALPATHLAB | |
|---|---|
| Ingresos | ₹21.72b |
| Coste de los ingresos | ₹9.28b |
| Beneficio bruto | ₹12.44b |
| Otros gastos | ₹9.14b |
| Beneficios | ₹3.30b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 39.72 |
| Margen bruto | 57.27% |
| Margen de beneficio neto | 15.19% |
| Ratio deuda/patrimonio | 16.6% |
¿Cómo se ha desempeñado LALPATHLAB a largo plazo?
Ver rendimiento histórico y comparativa